MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on September 23, 2005; DOI: 10.1124/mol.105.012419


0026-895X/05/6806-1839-1851$20.00
Mol Pharmacol 68:1839-1851, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.012419v1
68/6/1839    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuryatov, A.
Right arrow Articles by Lindstrom, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuryatov, A.
Right arrow Articles by Lindstrom, J.

Nicotine Acts as a Pharmacological Chaperone to Up-Regulate Human {alpha}4{beta}2 Acetylcholine Receptors

A. Kuryatov, J. Luo, J. Cooper, and J. Lindstrom

Department of Neuroscience, University of Pennsylvania Medical School, Philadelphia, Pennsylvania

Human neuronal nicotinic acetylcholine receptor (AChR) {alpha}4 subunits and an {alpha}4 mutant (S247F{alpha}4) found in autosomal-dominant nocturnal frontal lobe epilepsy (ADNFLE) were expressed along with {beta}2 in permanently transfected tsA201 human embryonic kidney cell lines. Their sensitivity to activation, desensitization, and up-regulation by cholinergic ligands was investigated. Up-regulation after 3 to 24 h resulted primarily from an increase in assembly of AChRs from large pools of unassembled subunits, but up-regulation also resulted from a 5-fold increase in the lifetime of AChRs in the surface membrane. Up-regulation does not require current flow through surface membrane AChRs, because up-regulation occurs in the presence of the channel blocker mecamylamine and with the {alpha}4 mutant, which prevents nearly all AChR function. Both membrane-permeable ligands like nicotine and much less permeable quaternary amine cholinergic ligands can act as pharmacological chaperones within the endoplasmatic reticulum to promote the assembly of AChRs. Agonists are more potent pharmacological chaperones than antagonists, presumably because activated or desensitized conformations assemble more efficiently. Assembly intermediates are disrupted by solubilization in Triton X-100, but chemical cross-linking stabilizes a putative assembly intermediate approximately the size of an {alpha}4{beta}2{alpha}4{beta}2 tetramer.


Received March 3, 2005; accepted September 23, 2005

Address correspondence to: Dr. Jon Lindstrom, Department of Neuroscience, University of Pennsylvania Medical School, 217 Stemmler Hall 36th and Hamilton Walk, Philadelphia, PA 19104. E-mail: jslkk{at}mail.med.upenn.edu




This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
X. W. Fu, J. Lindstrom, and E. R. Spindel
Nicotine Activates and Up-Regulates Nicotinic Acetylcholine Receptors in Bronchial Epithelial Cells
Am. J. Respir. Cell Mol. Biol., July 1, 2009; 41(1): 93 - 99.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. D. Son, F. J. Moss, B. N. Cohen, and H. A. Lester
Nicotine Normalizes Intracellular Subunit Stoichiometry of Nicotinic Receptors Carrying Mutations Linked to Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
Mol. Pharmacol., May 1, 2009; 75(5): 1137 - 1148.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. Liu, A. M. McGlinn, A. Fernandes, A. H. Milam, C. E. Strang, M. E. Andison, J. M. Lindstrom, K. T. Keyser, and R. A. Stone
Nicotinic Acetylcholine Receptor Subunits in Rhesus Monkey Retina
Invest. Ophthalmol. Vis. Sci., March 1, 2009; 50(3): 1408 - 1415.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. V. Kenny, S. L. Cousins, L. Pinho, and F. A. Stephenson
The Integrity of the Glycine Co-agonist Binding Site of N-Methyl-D-aspartate Receptors Is a Functional Quality Control Checkpoint for Cell Surface Delivery
J. Biol. Chem., January 2, 2009; 284(1): 324 - 333.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
X. A. Perez, T. Bordia, J. M. McIntosh, S. R. Grady, and M. Quik
Long-Term Nicotine Treatment Differentially Regulates Striatal {alpha}6{alpha}4{beta}2* and {alpha}6(Non{alpha}4){beta}2* nAChR Expression and Function
Mol. Pharmacol., September 1, 2008; 74(3): 844 - 853.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Moroni, R. Vijayan, A. Carbone, R. Zwart, P. C. Biggin, and I. Bermudez
Non-Agonist-Binding Subunit Interfaces Confer Distinct Functional Signatures to the Alternate Stoichiometries of the {alpha}4{beta}2 Nicotinic Receptor: An {alpha}4-{alpha}4 Interface Is Required for Zn2+ Potentiation
J. Neurosci., July 2, 2008; 28(27): 6884 - 6894.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
J. Lindstrom
'Seronegative' myasthenia gravis is no longer seronegative
Brain, July 1, 2008; 131(7): 1684 - 1685.
[Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Kuryatov, J. Onksen, and J. Lindstrom
Roles of Accessory Subunits in {alpha}4{beta}2* Nicotinic Receptors
Mol. Pharmacol., July 1, 2008; 74(1): 132 - 143.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Song, H. S. Sekhon, X. W. Fu, M. Maier, Y. Jia, J. Duan, B. J. Proskosil, C. Gravett, J. Lindstrom, G. P. Mark, et al.
Activated Cholinergic Signaling Provides a Target in Squamous Cell Lung Carcinoma
Cancer Res., June 15, 2008; 68(12): 4693 - 4700.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Kabbani, M. P. Woll, R. Levenson, J. M. Lindstrom, and J.-P. Changeux
Intracellular complexes of the 2 subunit of the nicotinic acetylcholine receptor in brain identified by proteomics
PNAS, December 18, 2007; 104(51): 20570 - 20575.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. Rezvani, Y. Teng, D. Shim, and M. De Biasi
Nicotine Regulates Multiple Synaptic Proteins by Inhibiting Proteasomal Activity
J. Neurosci., September 26, 2007; 27(39): 10508 - 10519.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Teper, D. Whyte, E. Cahir, H. A. Lester, S. R. Grady, M. J. Marks, B. N. Cohen, C. Fonck, T. McClure-Begley, J. M. McIntosh, et al.
Nicotine-Induced Dystonic Arousal Complex in a Mouse Line Harboring a Human Autosomal-Dominant Nocturnal Frontal Lobe Epilepsy Mutation
J. Neurosci., September 19, 2007; 27(38): 10128 - 10142.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. Nashmi, C. Xiao, P. Deshpande, S. McKinney, S. R. Grady, P. Whiteaker, Q. Huang, T. McClure-Begley, J. M. Lindstrom, C. Labarca, et al.
Chronic Nicotine Cell Specifically Upregulates Functional {alpha}4* Nicotinic Receptors: Basis for Both Tolerance in Midbrain and Enhanced Long-Term Potentiation in Perforant Path
J. Neurosci., August 1, 2007; 27(31): 8202 - 8218.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. C. Perry, D. Mao, A. B. Gold, J. M. McIntosh, J. C. Pezzullo, and K. J. Kellar
Chronic Nicotine Differentially Regulates {alpha}6- and beta3-Containing Nicotinic Cholinergic Receptors in Rat Brain
J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 306 - 315.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
L. Tapia, A. Kuryatov, and J. Lindstrom
Ca2+ Permeability of the ({alpha}4)3(beta2)2 Stoichiometry Greatly Exceeds That of ({alpha}4)2(beta2)3 Human Acetylcholine Receptors
Mol. Pharmacol., March 1, 2007; 71(3): 769 - 776.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
D. S. McGehee
Nicotinic and Opioid Receptor Interactions in Nicotine Addiction
Mol. Interv., December 1, 2006; 6(6): 311 - 314.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Kishi and J. H. Steinbach
Role of the Agonist Binding Site in Up-Regulation of Neuronal Nicotinic {alpha}4beta2 Receptors
Mol. Pharmacol., December 1, 2006; 70(6): 2037 - 2044.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. Tumkosit, A. Kuryatov, J. Luo, and J. Lindstrom
beta3 Subunits Promote Expression and Nicotine-Induced Up-Regulation of Human Nicotinic {alpha}6* Nicotinic Acetylcholine Receptors Expressed in Transfected Cell Lines
Mol. Pharmacol., October 1, 2006; 70(4): 1358 - 1368.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y. Xiao, H. Fan, J. L. Musachio, Z.-L. Wei, S. K. Chellappan, A. P. Kozikowski, and K. J. Kellar
Sazetidine-A, A Novel Ligand That Desensitizes {alpha}4beta2 Nicotinic Acetylcholine Receptors without Activating Them
Mol. Pharmacol., October 1, 2006; 70(4): 1454 - 1460.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
F. Picard, D. Bruel, D. Servent, W. Saba, C. Fruchart-Gaillard, M.-A. Schollhorn-Peyronneau, D. Roumenov, E. Brodtkorb, S. Zuberi, A. Gambardella, et al.
Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study
Brain, August 1, 2006; 129(8): 2047 - 2060.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Moroni, R. Zwart, E. Sher, B. K. Cassels, and I. Bermudez
{alpha}4beta2 Nicotinic Receptors with High and Low Acetylcholine Sensitivity: Pharmacology, Stoichiometry, and Sensitivity to Long-Term Exposure to Nicotine
Mol. Pharmacol., August 1, 2006; 70(2): 755 - 768.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. E. McCallum, N. Parameswaran, T. Bordia, H. Fan, J. M. McIntosh, and M. Quik
Differential Regulation of Mesolimbic {alpha}3/{alpha}6beta2 and {alpha}4beta2 Nicotinic Acetylcholine Receptor Sites and Function after Long-Term Oral Nicotine to Monkeys
J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 381 - 388.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics